IBB: Beyond The 2025 Surge, Biotech Breakout
Source: SeekingAlpha
2026-01-27 05:10:39 ET
After a multi-year drought, the iShares Biotechnology ETF ( IBB ) has been quietly having a fantastic run, returning about 28% for 2025, dwarfing its modest returns in 2023, alongside losses in 2022, 2024, amid a renewed risk appetite, a healthy environment of IPO & M&A activity, alongside a sturdy show by large-cap biotechs, where IBB derives its weights from....
Read the full article on Seeking Alpha
For further details see:
IBB: Beyond The 2025 Surge, Biotech Breakout
Invesco Nasdaq Biotechnology ETF
NASDAQ: IBBQ
IBBQ Trading
2.73% G/L:
$29.78 Last:
10,774 Volume:
$29.51 Open:
